Point72 Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,283,292
| Closed | -$7.29M | – | 1345 |
|
|
2024
Q4 | $7.29M | Buy |
+5,283,292
| New | +$7.29M | 0.02% | 611 |
|
|
2023
Q4 | – | Sell |
-7,491
| Closed | -$28K | – | 1486 |
|
|
2023
Q3 | $28K | Sell |
7,491
-952,530
| -99% | -$3.56M | ﹤0.01% | 1560 |
|
|
2023
Q2 | $4.1M | Buy |
+960,021
| New | +$4.1M | 0.01% | 707 |
|
|
2022
Q3 | – | Sell |
-135,800
| Closed | -$983K | – | 1067 |
|
|
2022
Q2 | $983K | Sell |
135,800
-572,200
| -81% | -$4.14M | ﹤0.01% | 846 |
|
|
2022
Q1 | $9.14M | Buy |
708,000
+377,700
| +114% | +$4.88M | 0.04% | 491 |
|
|
2021
Q4 | $5.27M | Buy |
+330,300
| New | +$5.27M | 0.02% | 614 |
|
|
2019
Q2 | – | Sell |
-917,896
| Closed | -$12.5M | – | 1258 |
|
|
2019
Q1 | $12.5M | Buy |
+917,896
| New | +$12.5M | 0.06% | 304 |
|
|
2018
Q4 | – | Sell |
-150,000
| Closed | -$2.48M | – | 875 |
|
|
2018
Q3 | $2.48M | Sell |
150,000
-162,800
| -52% | -$2.69M | 0.01% | 593 |
|
|
2018
Q2 | $4.38M | Buy |
+312,800
| New | +$4.38M | 0.02% | 507 |
|
|
2017
Q1 | – | Sell |
-601,034
| Closed | -$16.9M | – | 726 |
|
|
2016
Q4 | $16.9M | Buy |
+601,034
| New | +$16.9M | 0.12% | 199 |
|
|
2016
Q3 | – | Sell |
-37,500
| Closed | -$633K | – | 668 |
|
|
2016
Q2 | $633K | Sell |
37,500
-93,700
| -71% | -$1.58M | ﹤0.01% | 582 |
|
|
2016
Q1 | $2.79M | Buy |
+131,200
| New | +$2.79M | 0.02% | 474 |
|